Can a zapping helmet ease Parkinson's tremors and speech problems?

NCT ID NCT07721688

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial investigates whether a non-invasive brain stimulation technique called temporal interference stimulation (TIS) can improve motor and speech function in people with Parkinson's disease. TIS uses two high-frequency electrical fields to precisely target deep brain regions without surgery. Sixty participants with mild-to-moderate Parkinson's will receive either real TIS or a sham (placebo) stimulation over five days. Researchers will measure changes in movement, balance, and speech, and use fMRI to track brain activity changes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
temporal interference stimulation (TIS) — a non-invasive brain stimulation device
What this could lead to
If effective, TIS could offer a non-invasive, drug-free option to improve movement and speech in Parkinson's disease.
What could go wrong
This is an early-stage trial with 60 participants, so results may not apply broadly. The sham-controlled design means some may receive no benefit, and individual responses may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (PD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Rehabilitation Medicine, The First Affiliated Hospital, Sun Yat-sen University

    RECRUITING

    Guangzhou, Guangdong, 510000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.